clofibrate has been researched along with Muscular Diseases in 33 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Muscular Diseases: Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.
Excerpt | Relevance | Reference |
---|---|---|
"Clofibrate has been considered to be a relatively safe antidiuretic in the treatment of diabetes insipidus." | 7.66 | Clofibrate-induced myopathy in patients with diabetes insipidus. ( Chihara, K; Fujita, T; Matsukura, S; Matsumoto, J; Yoshimoto, Y, 1980) |
"Acute inflammatory muscular syndromes secondary to clofibrate therapy are rare." | 3.67 | [Atypical muscular syndrome with myolysis during long-term treatment with fibrates]. ( Brechenmacher, C; Chauvin, M; Zupan, M, 1988) |
"Clofibrate has been considered to be a relatively safe antidiuretic in the treatment of diabetes insipidus." | 3.66 | Clofibrate-induced myopathy in patients with diabetes insipidus. ( Chihara, K; Fujita, T; Matsukura, S; Matsumoto, J; Yoshimoto, Y, 1980) |
"Severe cases of rhabdomyolysis are rarer, but may have a significant mortality." | 2.41 | Myopathy and rhabdomyolysis with lipid-lowering drugs. ( Hodel, C, 2002) |
"Clofibrate has particular dangers in patients with uraemia or hypoproteinaemia, and we recommend that it be used with great caution in patients with renal disease." | 1.26 | Clofibrate-induced complications in renal disease: a case report. ( Gregory, MC; Pokroy, N; Ress, S, 1977) |
" If such therapy is contemplated it must be cautiously instituted at low dosage and the patient monitored by regular assessment of serum C." | 1.25 | Clofibrate-induced muscle damage in patients with chronic renal failure. ( Alvarez-Ude, F; Kerr, DN; Pierides, AM, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (84.85) | 18.7374 |
1990's | 2 (6.06) | 18.2507 |
2000's | 3 (9.09) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Okada, M | 1 |
Inoue, Y | 1 |
Ube, M | 1 |
Sano, F | 1 |
Ikeda, I | 1 |
Sugimoto, J | 1 |
Takagi, S | 1 |
Rimon, D | 1 |
Ludatscher, R | 1 |
Cohen, L | 1 |
Schneider, J | 2 |
Heidemann, H | 1 |
Bock, KD | 1 |
Wójcicki, J | 1 |
Matsukura, S | 1 |
Matsumoto, J | 1 |
Chihara, K | 1 |
Yoshimoto, Y | 1 |
Fujita, T | 1 |
Mühlfellner, G | 1 |
Kaffarnik, H | 1 |
Kumamoto, T | 1 |
Hodel, C | 1 |
Pierides, AM | 1 |
Alvarez-Ude, F | 1 |
Kerr, DN | 1 |
Rumpf, KW | 2 |
Albers, R | 1 |
Scheler, F | 2 |
Pokroy, N | 1 |
Ress, S | 1 |
Gregory, MC | 1 |
Abourizk, N | 1 |
Khalil, BA | 1 |
Bahuth, N | 1 |
Afifi, AK | 1 |
Bojs, G | 1 |
Fahlén, M | 1 |
Lapidus, L | 1 |
Cario, WR | 1 |
Hoffmann, J | 1 |
Hübschmann, K | 1 |
Kunze, D | 1 |
Regling, G | 1 |
Colombo, L | 1 |
Monarca, A | 1 |
Goldberg, D | 1 |
Zanetta, R | 1 |
Kijima, Y | 2 |
Makise, J | 1 |
Sasaoka, T | 2 |
Kanayama, M | 2 |
Kubota, S | 2 |
Smals, AG | 1 |
Beex, LV | 1 |
Kloppenborg, PW | 1 |
Teräväinen, H | 1 |
Larsen, A | 1 |
Hillbom, M | 1 |
Quellhrost, E | 1 |
Magarian, GJ | 1 |
Lucas, LM | 1 |
Colley, C | 1 |
Erkul, I | 1 |
Yavuz, H | 1 |
Ozel, A | 1 |
Chauvin, M | 1 |
Zupan, M | 1 |
Brechenmacher, C | 1 |
Rush, P | 1 |
Baron, M | 1 |
Kapusta, M | 1 |
Bardosi, A | 1 |
Scheidt, P | 1 |
Goebel, HH | 1 |
Bridgman, JF | 1 |
Rosen, SM | 1 |
Thorp, JM | 1 |
Denizot, M | 2 |
Fabre, J | 2 |
Pometta, D | 1 |
Wildi, E | 2 |
Micheli, H | 1 |
Berthoud, S | 1 |
Kra, SJ | 1 |
Katsilambros, N | 1 |
Braaten, J | 1 |
Ferguson, BD | 1 |
Bradley, RF | 1 |
Sekowski, I | 1 |
Samuel, P | 1 |
Smith, AF | 1 |
Macfie, WG | 1 |
Oliver, MF | 1 |
4 reviews available for clofibrate and Muscular Diseases
Article | Year |
---|---|
[Necrotizing myopathies].
Topics: Acute Disease; Aminocaproic Acid; Anti-Inflammatory Agents; Clofibrate; Diagnosis, Differential; Hum | 2001 |
Myopathy and rhabdomyolysis with lipid-lowering drugs.
Topics: Animals; Clofibrate; Female; Humans; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Muscular D | 2002 |
Gemfibrozil-induced myopathy.
Topics: Clofibrate; Drug Therapy, Combination; Gemfibrozil; Humans; Hypertriglyceridemia; Lovastatin; Male; | 1991 |
Clofibrate myopathy: a case report and a review of the literature.
Topics: Aged; Blood Sedimentation; Clofibrate; Creatine Kinase; Electromyography; Humans; Isoenzymes; Male; | 1986 |
1 trial available for clofibrate and Muscular Diseases
Article | Year |
---|---|
Clofibrate, serum enzymes, and muscle pain.
Topics: Adult; Alkaline Phosphatase; Anticholesteremic Agents; Aspartate Aminotransferases; Cholesterol; Clo | 1970 |
28 other studies available for clofibrate and Muscular Diseases
Article | Year |
---|---|
Skeletal muscle susceptibility to clofibrate induction of lesions in rats.
Topics: Animals; Clofibrate; Diaphragm; Female; Hypolipidemic Agents; Microscopy, Electron; Mitochondria, Mu | 2007 |
Clofibrate-induced muscular syndrome. Case report with ultrastructural findings and review of the literature.
Topics: Aged; Clofibrate; Humans; Male; Muscles; Muscular Atrophy; Muscular Diseases; Syndrome | 1984 |
Clinical importance of clofibrate induced increase of creatine kinase catalytic activity concentration in serum.
Topics: Clofibrate; Creatine Kinase; Humans; Hyperlipidemias; Male; Middle Aged; Muscular Diseases | 1981 |
[Rhabdomyolysis with acute renal failure due to bezafibrate].
Topics: Acute Kidney Injury; Bezafibrate; Clofibrate; Clofibric Acid; Humans; Male; Middle Aged; Muscular Di | 1981 |
[Current data on adverse effects of clofibrate].
Topics: Biliary Tract Diseases; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Clofibrate; | 1980 |
Clofibrate-induced myopathy in patients with diabetes insipidus.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Clofibrate; Creatine Kinase; Diabetes | 1980 |
Creatinekinase in hyperlipoproteinemic patients treated with clofibrate.
Topics: Clofibrate; Creatine Kinase; Female; Humans; Hyperlipoproteinemias; Male; Middle Aged; Muscular Dise | 1980 |
Clofibrate-induced muscle damage in patients with chronic renal failure.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Butyrates; Cholesterol; Clofibrate; Creati | 1975 |
Letter: Clofibrate-induced myopathy syndrome.
Topics: Adult; Clofibrate; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hypothyroidism; Kidney | 1976 |
Clofibrate-induced complications in renal disease: a case report.
Topics: Adult; Clofibrate; Humans; Male; Muscular Diseases; Nephrotic Syndrome; Peripheral Nervous System Di | 1977 |
Clofibrate-induced muscular syndrome. Report of a case with clinical, electromyographic and pathologic observations.
Topics: Adult; Capillaries; Clofibrate; Creatine Kinase; Diabetes Insipidus; Electromyography; Female; Human | 1979 |
[Clofibrate-induced muscle problems].
Topics: Adult; Aged; Clofibrate; Female; Humans; Male; Middle Aged; Muscular Diseases | 1979 |
Myopathy induced by clofibrate treatment in normolipaemic patients.
Topics: Child; Clofibrate; Creatine Kinase; Diabetes Insipidus; Female; Humans; Injections, Intravenous; Lip | 1979 |
[Tolerability and side-effects of bis-(hydroxy-2-ethylthio)-1,10-decane (BS 530) as compared with clofibrate in the therapy of hyperlipemia].
Topics: Clofibrate; Fatty Alcohols; Gastrointestinal Diseases; Headache; Humans; Hyperlipidemias; Hyperlipop | 1979 |
[The adverse actions of clofibrate in chronic hemodialysis patients--acute muscular syndrome and others (author's transl)].
Topics: Acute Disease; Adult; Clofibrate; Female; Humans; Male; Middle Aged; Muscular Diseases; Renal Dialys | 1978 |
Untoward effects of clofibrate in hemodialyzed patients.
Topics: Clofibrate; Humans; Hyperlipidemias; Muscular Diseases; Renal Dialysis; Uremia | 1977 |
Clofibrate-induced muscle damage with myoglobinuria and cardiomyopathy.
Topics: Adolescent; Cardiomyopathies; Clofibrate; Diabetes Insipidus; Humans; Male; Muscular Diseases; Myogl | 1977 |
Clofibrate-induced myopathy in the rat.
Topics: Animals; Clofibrate; Female; Microscopy, Electron; Muscles; Muscular Diseases; Rats; Time Factors | 1977 |
[Diabetic nephropathy, hypothyroidism and colfibrate-induced myopathy (author's transl)].
Topics: Adult; Clofibrate; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabet | 1976 |
Clofibrate treatment of neonatal jaundice.
Topics: Animals; Clofibrate; Humans; Infant, Newborn; Jaundice, Neonatal; Muscular Diseases; Rats | 1991 |
[Atypical muscular syndrome with myolysis during long-term treatment with fibrates].
Topics: Clofibrate; Creatine Kinase; Fructose-Bisphosphate Aldolase; Humans; Male; Middle Aged; Muscular Dis | 1988 |
Mitochondrial myopathy--a result of clofibrate/etofibrate treatment? Case report.
Topics: Aged; Clofibrate; Clofibric Acid; Humans; Hypolipidemic Agents; Kearns-Sayre Syndrome; Male; Microsc | 1985 |
Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia.
Topics: Adult; Binding Sites; Blood Protein Disorders; Clofibrate; Female; Fructose-Bisphosphate Aldolase; H | 1972 |
Clofibrate, nephrotic syndrome, and histological changes in muscle.
Topics: Adult; Clofibrate; Humans; Male; Muscles; Muscular Diseases; Nephrotic Syndrome | 1973 |
[Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome].
Topics: Adult; Arteriosclerosis; Cholesterol; Clofibrate; Glomerulonephritis; Humans; Hyperlipidemias; Male; | 1973 |
Muscle syndrome with clofibrate usage.
Topics: Clofibrate; Electromyography; Female; Humans; Middle Aged; Muscular Diseases | 1974 |
Muscular syndrome after clofibrate.
Topics: Adult; Clofibrate; Female; Humans; Muscular Diseases | 1972 |
Clofibrate-induced acute muscular syndrome.
Topics: Acute Disease; Aspartate Aminotransferases; Clofibrate; Creatine Kinase; Female; Humans; Male; Middl | 1972 |